YSYumeng Shi

Yumeng Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yumeng Shi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Chunxia Li

    State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China

    2 shared publications
  • Jing Liu

    State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China

    2 shared publications
  • Qiaoyu He

    State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China

    2 shared publications
  • Xiaopeng Chen

    Institute of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China

    2 shared publications
  • Fuqiang Liang

    College of Food Science and Engineering, Collaborative Innovation Center for Modern Grain Circulation and Safety, Nanjing University of Finance and Economics, Nanjing 210023, China

    1 shared publication
  • Hong Xing

    Institute of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China

    1 shared publication

Latest Publications

  • Open Access

    Integrated UPLC-Q-TOF-MS/MS and Network Pharmacology Approach to Investigating the Metabolic Profile of Marein of Coreopsis tinctoria Nutt.

    by Jing Liu, Xuejing Cheng, Xin Zheng, Yumeng Shi, Chunxia Li, Qiaoyu He, Yue Li, Xiaopeng Chen

    Marein is the main active compound of Coreopsis tinctoria Nutt., and its main activities include antioxidant, hypoglycemic, and hypotensive. After oral administration of marein, the blood concentration of marein is low. The metabolites of marein have not been reported systematically. In this study, a rapid and systematic method based on ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS/MS) was established to detect metabolites of marein in vivo (plasma and urine) after oral administration and injection. Sixty-one metabolites were identified. The metabolites are formed through a wide range of metabolic reactions, including hydroxylation, glucuronidation, methylation, hydrolysis, and desorption of hydrogen. The liver microsome incubation was further used to investigate the metabolic rate of marein. Network pharmacology was applied to study the targets and pathways of marein and its metabolites. Marein and its metabolites act on the same targets to enhance the therapeutic effect. This research illuminates the metabolites and metabolic reaction of marein and establishes a basis for the development and rational utilization of C. tinctoria. Meanwhile, the analysis of prototype and metabolites together by network pharmacology techniques could provide a methodology for the study of component activity.


  • Open Access

    Combining Network Pharmacology with Molecular Docking for Mechanistic Research on Thyroid Dysfunction Caused by Polybrominated Diphenyl Ethers and Their Metabolites

    by Qiaoyu He, Xiaopeng Chen, Jing Liu, Chunxia Li, Hong Xing, Yumeng Shi, Qian Tang

    Network pharmacology was used to illuminate the targets and pathways of polybrominated diphenyl ethers (PBDEs) causing thyroid dysfunction. A protein‐protein interaction (PPI) network was constructed. Molecular docking was applied to analyze PBDEs and key targets according to the network pharmacology results. A total of 247 targets were found to be related to 16 PBDEs. Ten key targets with direct action were identified, including the top five PIK3R1, MAPK1, SRC, RXRA, and TP53. Gene Ontology (GO) functional enrichment analysis identified 75 biological items. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis identified 62 pathways mainly related to the regulation of the thyroid hormone signaling pathway, MAPK signaling pathway, PI3K‐Akt signaling, pathways in cancer, proteoglycans in cancer, progesterone‐mediated oocyte maturation, and others. The molecular docking results showed that BDE‐99, BDE‐153, 5‐OH‐BDE47, 5 ′‐OH‐BDE99, 5‐BDE47 sulfate, and 5 ′‐BDE99 sulfate have a good binding effect with the kernel targets. PBDEs could interfere with the thyroid hormone endocrine through multiple targets and biological pathways, and metabolites demonstrated stronger effects than the prototypes. This research provides a basis for further research on the toxicological effects and molecular mechanisms of PBDEs and their metabolites. Furthermore, the application of network pharmacology to the study of the toxicity mechanisms of environmental pollutants provides a new methodology for environmental toxicology.